Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics

Cytochrome P450 (CYP) 2D6 is expressed in liver, brain and other extrahepatic tissues where it metabolizes a range of centrally acting drugs and toxins. As ethanol can induce CYP2D in rat brain, we hypothesized that CYP2D6 expression is higher in brains of human alcoholics. We examined regional and cellular expression of CYP2D6 mRNA and protein by RT‐PCR, Southern blotting, slot blotting, immunoblotting and immunocytochemistry. A significant correlation was found between mean mRNA and CYP2D6 protein levels across 13 brain regions. Higher expression was detected in 13 brain regions of alcoholics (n = 8) compared to nonalcoholics (n = 5) (anovap < 0.0001). In hippocampus this was localized in CA1–3 pyramidal cells and dentate gyrus granular neurons. In cerebellum this was localized in Purkinje cells and their dendrites. Both of these brain regions, and these same cell‐types, are known to be susceptible to alcohol damage. For one case, a poor metabolizer (CYP2D6*4/*4), there was no detectable CYP2D6 protein, confirming the specificity of the antibody used. These data suggest that in alcoholics elevated brain CYP2D6 expression may contribute to altered sensitivity to centrally acting drugs and to the mediation of neurotoxic and behavioral effects of alcohol.

[1]  R. Tyndale,et al.  Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brain. , 2001, Biochemical pharmacology.

[2]  R. Tyndale,et al.  Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates. , 2001, Pharmacogenetics.

[3]  M. Eichelbaum,et al.  Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain. , 2001, Pharmacogenetics.

[4]  N. Avadhani,et al.  Accumulation of Mitochondrial P450MT2, NH2-terminal Truncated Cytochrome P4501A1 in Rat Brain during Chronic Treatment with β-Naphthoflavone , 2000, The Journal of Biological Chemistry.

[5]  G. Tucker,et al.  The 1'-hydroxylation of Rac-bufuralol by rat brain microsomes. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[6]  R. Tyndale,et al.  Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment. , 2000, Biochemical pharmacology.

[7]  M. Galteau,et al.  Short communication. The effects of drinking and smoking on the CYP2D6 metabolic capacity. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[8]  H. Soininen,et al.  A volumetric MRI study of the hippocampus in type 1 and 2 alcoholism , 2000, Behavioural Brain Research.

[9]  M. Keshavan,et al.  Hippocampal volume in adolescent-onset alcohol use disorders. , 2000, The American journal of psychiatry.

[10]  C. Bouras,et al.  Cytochrome P-450 activities in human and rat brain microsomes , 2000, Brain Research.

[11]  E. Akarsu,et al.  Effects of Chronic Ethanol Administration on Serotonin Metabolism in the Various Regions of the Rat Brain , 2000, Neurochemical Research.

[12]  K. Husgafvel‐Pursiainen,et al.  CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behaviour. , 2000, Pharmacogenetics.

[13]  R. Tyndale,et al.  Regional and cellular distribution of CYP2D subfamily members in rat brain , 2000, Xenobiotica; the fate of foreign compounds in biological systems.

[14]  G. Kearns,et al.  Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data. , 1999, Pharmacogenetics.

[15]  R. Tyndale,et al.  Characterization of cytochrome P-450 2D1 activity in rat brain: high-affinity kinetics for dextromethorphan. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[16]  C. Lieber.  Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)--a review. , 1999, Alcoholism, clinical and experimental research.

[17]  C. Marsden,et al.  Expression and localisation of CYP2D enzymes in rat basal ganglia , 1999, Brain Research.

[18]  E. Akarsu,et al.  Dopaminergic and serotonergic alterations in the rat brain during ethanol withdrawal: association with behavioral signs. , 1998, Drug and alcohol dependence.

[19]  V. Ravindranath,et al.  Metabolism of xenobiotics in the central nervous system: implications and challenges. , 1998, Biochemical pharmacology.

[20]  S. Imaoka,et al.  Dopamine formation from tyramine by CYP2D6. , 1998, Biochemical and biophysical research communications.

[21]  T. Terao,et al.  Tardive dyskinesia and debrisoquine 4-hydroxylase (CYP2D6) genotype in Japanese schizophrenics , 1998, Schizophrenia Research.

[22]  C. Duport,et al.  Yeast expressed cytochrome P450 2D6 (CYP2D6) exposed on the external face of plasma membrane is functionally competent. , 1998, Molecular pharmacology.

[23]  B. Volk,et al.  Phenytoin alters Purkinje cell axon morphology and targeting in vitro , 1998, Acta Neuropathologica.

[24]  L. Thal,et al.  Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer's disease , 1998, Neurology.

[25]  G. Murray,et al.  Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain. , 1998, Biochemical pharmacology.

[26]  P. Jenner,et al.  P450 enzymes and Parkinson's disease: The story so far , 1998, Movement disorders : official journal of the Movement Disorder Society.

[27]  C. Goodlett,et al.  Alcohol-induced Purkinje cell loss depends on developmental timing of alcohol exposure and correlates with motor performance. , 1998, Brain research. Developmental brain research.

[28]  O. Pomerleau.  Endogenous opioids and smoking: A review of progress and problems , 1998, Psychoneuroendocrinology.

[29]  M. Wadelius,et al.  Induction of CYP2D6 in pregnancy , 1997, Clinical pharmacology and therapeutics.

[30]  J. Idle,et al.  CYP2D6 genotype and smoking behaviour in cigarette smokers. , 1997, Pharmacogenetics.

[31]  J. Bloomquist,et al.  Potential metabolic bioactivation pathways involving cyclic tertiary amines and azaarenes. , 1997, Chemical research in toxicology.

[32]  H. Strobel,et al.  Regulation of expression of cytochrome P-450 2D mRNA in rat brain with steroid hormones , 1997, Brain Research.

[33]  M. Ingelman-Sundberg,et al.  Enzyme-specific transport of rat liver cytochrome P450 to the Golgi apparatus. , 1996, Archives of biochemistry and biophysics.

[34]  C. S. Yang,et al.  Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes. , 1996, Archives of biochemistry and biophysics.

[35]  J. Gustafsson,et al.  Cytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene. , 1996, Molecular pharmacology.

[36]  A. Cho,et al.  Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. , 1996, Biochemical pharmacology.

[37]  P. Emson,et al.  Regional distribution of cytochrome P450 2D1 in the rat central nervous system , 1996, The Journal of comparative neurology.

[38]  A. Hodgson,et al.  Expression of multiple forms of brain cytochrome P450. , 1995, Toxicology letters.

[39]  C. Alling,et al.  Intermittent ethanol exposure of adult rats: hippocampal cell loss after one month of treatment. , 1995, Alcohol and alcoholism.

[40]  J. Broome,et al.  Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. , 1995, Cancer research.

[41]  A. Cribb,et al.  Antipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[42]  M. Boyd,et al.  Brain mitochondrial cytochromes P450: xenobiotic metabolism, presence of multiple forms and their selective inducibility. , 1995, Archives of biochemistry and biophysics.

[43]  P. Beaune,et al.  Cytochrome P4502B follows a vesicular route to the plasma membrane in cultured rat hepatocytes. , 1995, Gastroenterology.

[44]  G. Siest,et al.  Dextromethorphan O-demethylase activity in rat brain microsomes , 1995, Neuroscience Letters.

[45]  C. Montoliu,et al.  Ethanol‐Induced Oxygen Radical Formation and Lipid Peroxidation in Rat Brain: Effect of Chronic Alcohol Consumption , 1994, Journal of neurochemistry.

[46]  V. Camp,et al.  The effect of cocaine abuse on plasma levels of sulfated dopamine and salsolinol in alcoholics. , 1994, Alcohol.

[47]  U. Klotz,et al.  Extrahepatic Metabolism of Drugs in Humans , 1994, Clinical pharmacokinetics.

[48]  J. Gustafsson,et al.  Effect of ethanol on cytochrome P450 in the rat brain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[49]  G. Siest,et al.  Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain. , 1993, Biochemical pharmacology.

[50]  U. Meyer,et al.  Evolution of a highly polymorphic human cytochrome P450 gene cluster: CYP2D6. , 1992, Genomics.

[51]  Defeng Wu,et al.  Presence of functionally active cytochrome P‐450IIE1 in the plasma membrane of rat hepatocytes , 1992, Hepatology.

[52]  S. Ohta,et al.  Cytochrome P450 isozymes catalyzing 4‐hydroxylation of parkinsonism‐related compound 1,2,3,4‐tetrahydroisoquinoline in rat liver microsomes , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  F. Oesch,et al.  Mapping of phenytoin-inducible cytochrome P450 immunoreactivity in the mouse central nervous system , 1991, Neuroscience.

[54]  M. Eichelbaum,et al.  Thebaine O-demethylation to oripavine: genetic differences between two rat strains. , 1991, Xenobiotica; the fate of foreign compounds in biological systems.

[55]  L. Rothblum,et al.  Rapid, small-scale RNA isolation from tissue culture cells. , 1991, BioTechniques.

[56]  R. Tyndale,et al.  Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6. , 1991, Molecular pharmacology.

[57]  M. J. Coon,et al.  The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. , 1991, DNA and cell biology.

[58]  R. Pentney,et al.  Dendritic hypertrophy in Purkinje neurons of old Fischer 344 rats after long-term ethanol treatment. , 1990, Alcoholism, clinical and experimental research.

[59]  J. S. Miles,et al.  Identification of the primary gene defect at the cytochrome P450 CYP2D locus , 1990, Nature.

[60]  U. Meyer,et al.  Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification , 1990, The Lancet.

[61]  P. Beaune,et al.  Presence of functional cytochrome P-450 on isolated rat hepatocyte plasma membrane. , 1990, Hepatology.

[62]  R. Tyndale,et al.  The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins. , 1990, Archives of biochemistry and biophysics.

[63]  U. Meyer,et al.  The human CYP2D locus associated with a common genetic defect in drug oxidation: a G1934----A base change in intron 3 of a mutant CYP2D6 allele results in an aberrant 3' splice recognition site. , 1990, American journal of human genetics.

[64]  U. Meyer,et al.  Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: Relationship to the presence of immunoidentified cytochrome P‐450IID1 , 1990, Clinical pharmacology and therapeutics.

[65]  R. Skoda,et al.  The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. , 1989, American journal of human genetics.

[66]  R. D. Myers,et al.  A neuroanatomical substrate for alcohol drinking: Identification of tetrahydropapaveroline (THP)-reactive sites in the rat brain , 1989, Brain Research Bulletin.

[67]  M. Lang,et al.  Hepatic mitochondrial coumarin 7-hydroxylase: comparison with the microsomal enzyme. , 1988, Archives of biochemistry and biophysics.

[68]  D. Nebert,et al.  Characterization of the common genetic defect in humans deficient in debrisoquine metabolism , 1988, Nature.

[69]  C. Weitz,et al.  Synthesis of the skeleton of the morphine molecule by mammalian liver , 1987, Nature.

[70]  G. Siest,et al.  Subcellular distribution of cytochrome P-450 in the brain , 1986, Brain Research.

[71]  A. Brossi,et al.  Presence and formation of codeine and morphine in the rat. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[72]  E. Irle,et al.  Widespread neuroanatomical damage and learning deficits following chronic alcohol consumption or vitamin-B1 (thiamine) deficiency in rats , 1983, Behavioural Brain Research.

[73]  John Doull,et al.  Casarett and Doull's toxicology : the basic science of poisons , 2001 .

[74]  J. Riley,et al.  Morphological alterations in hippocampus after long-term alcohol consumption in mice. , 1978, Science.

[75]  R. D. Myers,et al.  Differential actions on voluntary alcohol intake of tetrahydroisoquinolines or a β-carboline infused chronically in the ventricle of the rat , 1977, Pharmacology Biochemistry and Behavior.

[76]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[77]  INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .

[78]  R. Michels,et al.  Progress in Psychiatry , 1904, The Hospital.

[79]  E. Meese,et al.  Debrisoquine hydroxylase gene polymorphism in meningioma , 2004, Acta Neuropathologica.

[80]  Pr M M Galteau.  The Effects of Drinking and Smoking on the CYP 2 D 6 Metabolic Capacity , 2000 .

[81]  R. Poulsom,et al.  Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 mRNA in human foetal and adult brain by in situ hybridization. , 1997, Xenobiotica; the fate of foreign compounds in biological systems.

[82]  A. Herz.  Endogenous opioid systems and alcohol addiction , 1997, Psychopharmacology.

[83]  D. Pessayre,et al.  Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis. , 1997, Journal of hepatology.

[84]  A. Somogyi,et al.  Morphine formation from codeine in rat brain: a possible mechanism of codeine analgesia. , 1990, Life sciences.

[85]  R. Skoda,et al.  The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms. , 1990, Pharmacology & therapeutics.

[86]  S. Phillips.  Cerebellar white matter after long-term ethanol consumption in mice. , 1990, Journal of studies on alcohol.